Altering Multitasking Behavior Using Low Current Brain Stimulation

Cognitive Change Clinical Trial

Official title:

Altering Multitasking Behavior Using Low Current Brain Stimulation

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT03873636
• Other study ID #: 1611020
• Status: Active, not recruiting
• Phase: N/A
• Start date: December 27, 2016
• Est. completion date: October 18, 2024

Study information

• Verified date: November 2023
• Source: Tufts University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study is designed to investigate multitasking deficits, with a particular interest in reducing costs related to dual-tasking (dividing attention between tasks) and task-switching (switching between tasks) using noninvasive brain stimulation.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 300
• Est. completion date: October 18, 2024
• Est. primary completion date: October 18, 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Must be able to participate in non invasive brain stimulation research

• Must be a fluent English speaker

• Must be at least 18 years old

• Must be right-handed

• Must have normal or corrected-to-normal vision

Exclusion Criteria:

• Any history of complications with non invasive brain stimulation research

• Any metallic implants in head

• Any implanted internal or external electrical stimulation device

• Any adverse reaction to tDCS or other forms of low current brain stimulation

• Any history of seizure

• Any history of head injury

• Any illness that caused brain injury

• Any other brain-related condition

• Any diagnosis of neurological or psychiatric disorder

• A sensitive scalp

Related Conditions & MeSH terms

• Cognitive Change

Intervention

Other:
• Stimulation via noninvasive brain stimulation systems
Active (at or below 2mA) stimulation targeting brain regions engaged in task-switching and dual-tasking for 30-40 minutes. Local IRB has determined the Soterix, Neuroelectrics, & Halo devices to be non-significant risk (NSR) devices via abbreviated investigational device exemption (IDE) procedure.

Locations

Country	Name	City	State
United States	Tufts University	Medford	Massachusetts

Sponsors (1)

Lead Sponsor	Collaborator
Tufts University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Response accuracy	Measuring accuracy (correct vs. incorrect answers) of responses to stimuli while dividing attention and switching between tasks	4 hours
Primary	Response latency	Measuring the amount of time (seconds) from when stimulus is presented to when participant answers prompt	4 hours